IBDEI13Z ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,17988,1,3,0)
;;=3^Multi-System Degeneration of the Autonomic Nervous System
;;^UTILITY(U,$J,358.3,17988,1,4,0)
;;=4^G90.3
;;^UTILITY(U,$J,358.3,17988,2)
;;=^5004162
;;^UTILITY(U,$J,358.3,17989,0)
;;=G91.2^^61^795^22
;;^UTILITY(U,$J,358.3,17989,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17989,1,3,0)
;;=3^NPH w/ Dementia w/ Behavioral Disturbances
;;^UTILITY(U,$J,358.3,17989,1,4,0)
;;=4^G91.2
;;^UTILITY(U,$J,358.3,17989,2)
;;=^5004174^F02.81
;;^UTILITY(U,$J,358.3,17990,0)
;;=G91.2^^61^795^23
;;^UTILITY(U,$J,358.3,17990,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17990,1,3,0)
;;=3^NPH w/ Dementia w/o Behavioral Disturbances
;;^UTILITY(U,$J,358.3,17990,1,4,0)
;;=4^G91.2
;;^UTILITY(U,$J,358.3,17990,2)
;;=^5004174^F02.80
;;^UTILITY(U,$J,358.3,17991,0)
;;=G30.8^^61^795^5
;;^UTILITY(U,$J,358.3,17991,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17991,1,3,0)
;;=3^Alzheimer's Diseases NEC
;;^UTILITY(U,$J,358.3,17991,1,4,0)
;;=4^G30.8
;;^UTILITY(U,$J,358.3,17991,2)
;;=^5003807
;;^UTILITY(U,$J,358.3,17992,0)
;;=G31.09^^61^795^16
;;^UTILITY(U,$J,358.3,17992,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17992,1,3,0)
;;=3^Frontotemporal Dementia NEC
;;^UTILITY(U,$J,358.3,17992,1,4,0)
;;=4^G31.09
;;^UTILITY(U,$J,358.3,17992,2)
;;=^329916
;;^UTILITY(U,$J,358.3,17993,0)
;;=G20.^^61^795^24
;;^UTILITY(U,$J,358.3,17993,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17993,1,3,0)
;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
;;^UTILITY(U,$J,358.3,17993,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,17993,2)
;;=^5003770^F02.81
;;^UTILITY(U,$J,358.3,17994,0)
;;=G20.^^61^795^25
;;^UTILITY(U,$J,358.3,17994,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17994,1,3,0)
;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
;;^UTILITY(U,$J,358.3,17994,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,17994,2)
;;=^5003770^F02.80
;;^UTILITY(U,$J,358.3,17995,0)
;;=G31.01^^61^795^26
;;^UTILITY(U,$J,358.3,17995,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17995,1,3,0)
;;=3^Pick's Disease
;;^UTILITY(U,$J,358.3,17995,1,4,0)
;;=4^G31.01
;;^UTILITY(U,$J,358.3,17995,2)
;;=^329915
;;^UTILITY(U,$J,358.3,17996,0)
;;=G23.1^^61^795^28
;;^UTILITY(U,$J,358.3,17996,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17996,1,3,0)
;;=3^Progressive Supranuclear Ophthalmoplegia
;;^UTILITY(U,$J,358.3,17996,1,4,0)
;;=4^G23.1
;;^UTILITY(U,$J,358.3,17996,2)
;;=^5003780
;;^UTILITY(U,$J,358.3,17997,0)
;;=Z79.2^^61^796^1
;;^UTILITY(U,$J,358.3,17997,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17997,1,3,0)
;;=3^Antibiotics
;;^UTILITY(U,$J,358.3,17997,1,4,0)
;;=4^Z79.2
;;^UTILITY(U,$J,358.3,17997,2)
;;=^321546
;;^UTILITY(U,$J,358.3,17998,0)
;;=Z79.01^^61^796^2
;;^UTILITY(U,$J,358.3,17998,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17998,1,3,0)
;;=3^Anticoagulants
;;^UTILITY(U,$J,358.3,17998,1,4,0)
;;=4^Z79.01
;;^UTILITY(U,$J,358.3,17998,2)
;;=^5063330
;;^UTILITY(U,$J,358.3,17999,0)
;;=Z79.02^^61^796^3
;;^UTILITY(U,$J,358.3,17999,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,17999,1,3,0)
;;=3^Antiplatelets/Antithrombotics
;;^UTILITY(U,$J,358.3,17999,1,4,0)
;;=4^Z79.02
;;^UTILITY(U,$J,358.3,17999,2)
;;=^5063331
;;^UTILITY(U,$J,358.3,18000,0)
;;=Z79.82^^61^796^4
;;^UTILITY(U,$J,358.3,18000,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,18000,1,3,0)
;;=3^Aspirin
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI13Z 3763 printed Sep 15, 2024@21:25:31 Page 2
IBDEI13Z ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,17988,1,3,0)
+2 ;;=3^Multi-System Degeneration of the Autonomic Nervous System
+3 ;;^UTILITY(U,$J,358.3,17988,1,4,0)
+4 ;;=4^G90.3
+5 ;;^UTILITY(U,$J,358.3,17988,2)
+6 ;;=^5004162
+7 ;;^UTILITY(U,$J,358.3,17989,0)
+8 ;;=G91.2^^61^795^22
+9 ;;^UTILITY(U,$J,358.3,17989,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,17989,1,3,0)
+12 ;;=3^NPH w/ Dementia w/ Behavioral Disturbances
+13 ;;^UTILITY(U,$J,358.3,17989,1,4,0)
+14 ;;=4^G91.2
+15 ;;^UTILITY(U,$J,358.3,17989,2)
+16 ;;=^5004174^F02.81
+17 ;;^UTILITY(U,$J,358.3,17990,0)
+18 ;;=G91.2^^61^795^23
+19 ;;^UTILITY(U,$J,358.3,17990,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,17990,1,3,0)
+22 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
+23 ;;^UTILITY(U,$J,358.3,17990,1,4,0)
+24 ;;=4^G91.2
+25 ;;^UTILITY(U,$J,358.3,17990,2)
+26 ;;=^5004174^F02.80
+27 ;;^UTILITY(U,$J,358.3,17991,0)
+28 ;;=G30.8^^61^795^5
+29 ;;^UTILITY(U,$J,358.3,17991,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,17991,1,3,0)
+32 ;;=3^Alzheimer's Diseases NEC
+33 ;;^UTILITY(U,$J,358.3,17991,1,4,0)
+34 ;;=4^G30.8
+35 ;;^UTILITY(U,$J,358.3,17991,2)
+36 ;;=^5003807
+37 ;;^UTILITY(U,$J,358.3,17992,0)
+38 ;;=G31.09^^61^795^16
+39 ;;^UTILITY(U,$J,358.3,17992,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,17992,1,3,0)
+42 ;;=3^Frontotemporal Dementia NEC
+43 ;;^UTILITY(U,$J,358.3,17992,1,4,0)
+44 ;;=4^G31.09
+45 ;;^UTILITY(U,$J,358.3,17992,2)
+46 ;;=^329916
+47 ;;^UTILITY(U,$J,358.3,17993,0)
+48 ;;=G20.^^61^795^24
+49 ;;^UTILITY(U,$J,358.3,17993,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,17993,1,3,0)
+52 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
+53 ;;^UTILITY(U,$J,358.3,17993,1,4,0)
+54 ;;=4^G20.
+55 ;;^UTILITY(U,$J,358.3,17993,2)
+56 ;;=^5003770^F02.81
+57 ;;^UTILITY(U,$J,358.3,17994,0)
+58 ;;=G20.^^61^795^25
+59 ;;^UTILITY(U,$J,358.3,17994,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,17994,1,3,0)
+62 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
+63 ;;^UTILITY(U,$J,358.3,17994,1,4,0)
+64 ;;=4^G20.
+65 ;;^UTILITY(U,$J,358.3,17994,2)
+66 ;;=^5003770^F02.80
+67 ;;^UTILITY(U,$J,358.3,17995,0)
+68 ;;=G31.01^^61^795^26
+69 ;;^UTILITY(U,$J,358.3,17995,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,17995,1,3,0)
+72 ;;=3^Pick's Disease
+73 ;;^UTILITY(U,$J,358.3,17995,1,4,0)
+74 ;;=4^G31.01
+75 ;;^UTILITY(U,$J,358.3,17995,2)
+76 ;;=^329915
+77 ;;^UTILITY(U,$J,358.3,17996,0)
+78 ;;=G23.1^^61^795^28
+79 ;;^UTILITY(U,$J,358.3,17996,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,17996,1,3,0)
+82 ;;=3^Progressive Supranuclear Ophthalmoplegia
+83 ;;^UTILITY(U,$J,358.3,17996,1,4,0)
+84 ;;=4^G23.1
+85 ;;^UTILITY(U,$J,358.3,17996,2)
+86 ;;=^5003780
+87 ;;^UTILITY(U,$J,358.3,17997,0)
+88 ;;=Z79.2^^61^796^1
+89 ;;^UTILITY(U,$J,358.3,17997,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,17997,1,3,0)
+92 ;;=3^Antibiotics
+93 ;;^UTILITY(U,$J,358.3,17997,1,4,0)
+94 ;;=4^Z79.2
+95 ;;^UTILITY(U,$J,358.3,17997,2)
+96 ;;=^321546
+97 ;;^UTILITY(U,$J,358.3,17998,0)
+98 ;;=Z79.01^^61^796^2
+99 ;;^UTILITY(U,$J,358.3,17998,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,17998,1,3,0)
+102 ;;=3^Anticoagulants
+103 ;;^UTILITY(U,$J,358.3,17998,1,4,0)
+104 ;;=4^Z79.01
+105 ;;^UTILITY(U,$J,358.3,17998,2)
+106 ;;=^5063330
+107 ;;^UTILITY(U,$J,358.3,17999,0)
+108 ;;=Z79.02^^61^796^3
+109 ;;^UTILITY(U,$J,358.3,17999,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,17999,1,3,0)
+112 ;;=3^Antiplatelets/Antithrombotics
+113 ;;^UTILITY(U,$J,358.3,17999,1,4,0)
+114 ;;=4^Z79.02
+115 ;;^UTILITY(U,$J,358.3,17999,2)
+116 ;;=^5063331
+117 ;;^UTILITY(U,$J,358.3,18000,0)
+118 ;;=Z79.82^^61^796^4
+119 ;;^UTILITY(U,$J,358.3,18000,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,18000,1,3,0)
+122 ;;=3^Aspirin
